Dr. Devi Nair ...

Dr. Devi Nair, MD

Claim this profile

Arrhythmia Research Group

Expert in Atrial Fibrillation
Studies Stroke
25 reported clinical trials
32 drugs studied

About Devi Nair, MD

Education:

  • Earned an MD from the University of Texas Southwestern Medical Center, Dallas, TX.
  • Completed Residency in Internal Medicine at the University of California, San Francisco (UCSF).
  • Undertook Fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology at UCSF.

Experience:

  • Specializes in cardiac electrophysiology with the Arrhythmia Research Group.
  • Received comprehensive training at UCSF, a leading academic medical center.

Affiliated Hospitals

Image of trial facility.
Arrhythmia Research Group
Image of trial facility.
St. Bernards Medical Center

Clinical Trials Devi Nair, MD is currently running

Image of trial facility.

WATCHMAN Device

for Atrial Fibrillation

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Recruiting1 award N/A3 criteria
Image of trial facility.

Catheter Ablation + HF Therapies

for Heart Failure and Atrial Fibrillation

Heart failure (HF) with preserved left ventricular function (pEF) is difficult clinical syndrome to treat effectively with few evidence based therapies. Atrial fibrillation (AF) is now an important co-morbidity being observed in 43% of patients with HFpEF. Rhythm control has not been studied in this population. Catheter ablation and antiarrhythmic drugs are rhythm control therapies that have been used for treatment of AF without HF or HF with reduced systolic function but have not been widely applied in HFpEF. No controlled comparative evaluation has been performed in HFpEF. The introduction of wireless pulmonary artery hemodynamic monitoring has permitted optimization of HF therapy in patients with chronic HF with reduced and preserved EF. Reduction in HF hospitalizations has been observed in post hoc analyses of HFpEF patients but has not been systematically applied in AF patients with HFpEF. In this study, we propose to study both rhythm control and optimized HF therapeutic approaches in an AF with HFpEF study population in a pilot study using a sequential two phase randomized controlled clinical trial design.
Recruiting3 awards Phase 413 criteria

More about Devi Nair, MD

Clinical Trial Related2 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Devi Nair, MD has experience with
  • Catheter Ablation
  • Laminar Left Atrial Appendage Closure System
  • Renal Denervation
  • Amulet™ 2 Left Atrial Appendage (LAA) Occluder
  • Insertion Of CardioMems Hemodynamic Monitor
  • Rate Or Rhythm Control Antiarrhythmic Drugs For Atrial Fibrillation

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Devi Nair, MD specialize in?
Is Devi Nair, MD currently recruiting for clinical trials?
Are there any treatments that Devi Nair, MD has studied deeply?
What is the best way to schedule an appointment with Devi Nair, MD?
What is the office address of Devi Nair, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security